Azienda Usl Reggio Emilia - Irccs
Clinical trials sponsored by Azienda Usl Reggio Emilia - Irccs, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Silent suffering: new tool could help spot hip pain in kids who Can't speak Results expected Dec 2026 (estimated)
- New study hopes to predict hodgkin lymphoma outcomes better Results expected Dec 2026 (estimated)
- Parkinson's gene mutation may raise cancer risk – large study investigates Results expected Dec 2026 (estimated)
- Study questions best surgery for High-Risk endometrial cancer Results expected Dec 2026 (estimated)
- Could a lifesaving leukemia drug harm Men's sexual health? Results expected Dec 2026 (estimated)